
 
 
 
 PARIS (Reuters) - France's public health authority has recommended people under 30 be given Pfizer's Comirnaty COVID-19 vaccine when available instead of Moderna Inc's Spikevax jab, which carried comparatively higher risks of heart-related problems. The Haute Autorite de Sante (HAS), which does not have legal power to ban or licence drugs but acts as an advisor to the French health sector, cited "very rare" risks linked to myocarditis, a heart disease, that had shown up in recent data on the Moderna vaccine and in a French study published on Monday.  
 To continue reading this article ... or Continue reading your article with a Medscape account Join the Top Medical Resource for Physicians Today. Free Membership! 
 
 
 
 
 
 
 
 
 
 
 Reuters Health Information2021 
 
 TOP PICKS FOR YOU 
 
 
 
 
 
 
